These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 10666398

  • 21. VEGF receptor signaling in tumor angiogenesis.
    McMahon G.
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [Abstract] [Full Text] [Related]

  • 22. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA.
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [Abstract] [Full Text] [Related]

  • 23. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
    Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10457-61. PubMed ID: 7479819
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
    Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H, Hallahan DE.
    Cancer Res; 2001 Mar 15; 61(6):2413-9. PubMed ID: 11289107
    [Abstract] [Full Text] [Related]

  • 25. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
    Hackett SF, Seidel C, Abraham S, Chadha R, Fortmann SD, Campochiaro PA, Cooke JP.
    Invest Ophthalmol Vis Sci; 2017 Feb 01; 58(2):1296-1303. PubMed ID: 28241318
    [Abstract] [Full Text] [Related]

  • 26. Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy.
    Yamada H, Yamada E, Ando A, Seo MS, Esumi N, Okamoto N, Vinores M, LaRochelle W, Zack DJ, Campochiaro PA.
    Am J Pathol; 2000 Feb 01; 156(2):477-87. PubMed ID: 10666377
    [Abstract] [Full Text] [Related]

  • 27. [Cell biology of intraocular vascular diseases].
    Ishibashi T.
    Nippon Ganka Gakkai Zasshi; 1999 Dec 01; 103(12):923-47. PubMed ID: 10643294
    [Abstract] [Full Text] [Related]

  • 28. Molecular pathogenesis of retinal and choroidal vascular diseases.
    Campochiaro PA.
    Prog Retin Eye Res; 2015 Nov 01; 49():67-81. PubMed ID: 26113211
    [Abstract] [Full Text] [Related]

  • 29. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
    Nambu H, Umeda N, Kachi S, Oshima Y, Akiyama H, Nambu R, Campochiaro PA.
    J Cell Physiol; 2005 Jul 01; 204(1):227-35. PubMed ID: 15648096
    [Abstract] [Full Text] [Related]

  • 30. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 1999 Nov 01; 30(5):1179-86. PubMed ID: 10534339
    [Abstract] [Full Text] [Related]

  • 31. Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.
    Lutty GA, McLeod DS, Bhutto I, Wiegand SJ.
    Invest Ophthalmol Vis Sci; 2011 Jun 08; 52(7):4039-47. PubMed ID: 21357392
    [Abstract] [Full Text] [Related]

  • 32. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R, Shen J, Gong YY, Seidel CP, Hackett SF, Kesavan K, Jacoby DB, Campochiaro PA.
    J Cell Physiol; 2010 Nov 08; 225(3):855-64. PubMed ID: 20607799
    [Abstract] [Full Text] [Related]

  • 33. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N.
    Recent Prog Horm Res; 2000 Nov 08; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [Abstract] [Full Text] [Related]

  • 34. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
    Drevs J, Müller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, Konerding MA, Allegrini PR, Wood J, Hennig J, Unger C, Marmé D.
    Cancer Res; 2002 Jul 15; 62(14):4015-22. PubMed ID: 12124335
    [Abstract] [Full Text] [Related]

  • 35. Vascular endothelial growth factor (VEGF) and its receptors.
    Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z.
    FASEB J; 1999 Jan 15; 13(1):9-22. PubMed ID: 9872925
    [Abstract] [Full Text] [Related]

  • 36. Angiogenesis in embryos and ischemic diseases.
    Breier G, Damert A, Plate KH, Risau W.
    Thromb Haemost; 1997 Jul 15; 78(1):678-83. PubMed ID: 9198238
    [Abstract] [Full Text] [Related]

  • 37. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
    Vinores SA, Derevjanik NL, Vinores MA, Okamoto N, Campochiaro PA.
    Adv Exp Med Biol; 2000 Jul 15; 476():129-38. PubMed ID: 10949661
    [Abstract] [Full Text] [Related]

  • 38. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
    Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 1998 Jan 15; 39(1):180-8. PubMed ID: 9430560
    [Abstract] [Full Text] [Related]

  • 39. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.
    Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA.
    Am J Pathol; 1997 Jul 15; 151(1):281-91. PubMed ID: 9212753
    [Abstract] [Full Text] [Related]

  • 40. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors.
    Schlaeppi JM, Wood JM.
    Cancer Metastasis Rev; 1999 Jul 15; 18(4):473-81. PubMed ID: 10855790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.